UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Lancet neurology, 2013-12, Vol.12 (12), p.1141-1150

2013

Volltextzugriff (PDF)

Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management

Journal of opioid management, 2018-01, Vol.5 (3), p.145-151

2018

Volltextzugriff (PDF)

Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial

Lancet neurology, 2015-12, Vol.14 (12), p.1161-1170

2015

Volltextzugriff (PDF)

Refocusing of Attention on Positive Events Using Monitoring-Based Feedback and Microinterventions for Patients With Chronic Musculoskeletal Pain in the PerPAIN Randomized Controlled Trial: Protocol for a Microrandomized Trial

JMIR research protocols, 2023-09, Vol.12, p.e43376-e43376

2023

Volltextzugriff (PDF)

Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers

Clinical therapeutics, 2008-11, Vol.30 (11), p.2051-2068

2008

Volltextzugriff (PDF)

Fibroblast growth on surface-modified dental implants: An in vitro study

Journal of biomedical materials research, 2003-03, Vol.64A (4), p.591-599

2003

Volltextzugriff (PDF)

A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain

Palliative medicine, 2012-01, Vol.26 (1), p.50-60

2012

Volltextzugriff (PDF)

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation

European journal of pain, 2009-01, Vol.13 (1), p.56-64

2009

Volltextzugriff (PDF)

Hair for brain trade-off, a metabolic bypass for encephalization

SpringerPlus, 2014-09, Vol.3 (1), p.562-562, Article 562

2014

Volltextzugriff (PDF)

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain

Supportive care in cancer, 2015-03, Vol.23 (3), p.823-830

2015

Volltextzugriff (PDF)

Low absolute bioavailability of oral naloxone in healthy subjects

International journal of clinical pharmacology and therapeutics, 2012-05, Vol.50 (5), p.360-367

2012

Volltextzugriff (PDF)

Dr. Meissner and colleagues reply to the Letter to the Editor from Andrew Wilcock entitled ‘Prolonged-release naloxone can cause systemic opioid withdrawal’

European journal of pain, 2009-10, Vol.13 (9), p.1002-1003

2009

Volltextzugriff (PDF)

Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain

The journal of pain, 2008-12, Vol.9 (12), p.1144-1154

2008

Volltextzugriff (PDF)

Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study

Rheumatic & musculoskeletal diseases open, 2017-01, Vol.3 (1), p.e000426-e000426

2017

Volltextzugriff (PDF)

Mykosen – Bedeutung in Medizin und Zahnmedizin, Diagnostik und Therapie

Zahnmedizin up2date, 2011-10, Vol.5 (5), p.489-513

2011

Volltextzugriff (PDF)

Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial

Advances in therapy, 2020-03, Vol.37 (3), p.1188-1202

2020

Volltextzugriff (PDF)

Efficacy and tolerability of liposomal polyvinylpyrrolidone-iodine hydrogel for the localized treatment of chronic infective, inflammatory, dermatoses: an uncontrolled pilot study

Clinical, cosmetic and investigational dermatology, 2017-01, Vol.10, p.373-384

2017

Volltextzugriff (PDF)

Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers

Expert opinion on investigational drugs, 2011-04, Vol.20 (4), p.427-439

2011

Volltextzugriff (PDF)

PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain

Parkinsonism & related disorders, 2016-01, Vol.22, p.e101-e102

2016

Volltextzugriff (PDF)

PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain

Parkinsonism & related disorders, 2016-01, Vol.22, p.e85-e85

2016

Volltextzugriff (PDF)

Efficacy of Conventional and Liposomal Povidone–Iodine in Infected Mesh Skin Grafts: An Exploratory Study

Infectious diseases and therapy, 2017-12, Vol.6 (4), p.545-555

2017

Volltextzugriff (PDF)

Meeting the Challenges of Opioid-Induced Constipation in Chronic Pain Management – A Novel Approach

Pharmacology, 2009-01, Vol.83 (1), p.10-17

2009

Volltextzugriff (PDF)

Prolonged release oxycodoneanaloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Lancet neurology, 2013-12, Vol.12 (12), p.1141-1150

2013

Volltextzugriff (PDF)

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension

CNS drugs, 2016-08, Vol.30 (8), p.749-760

2016

Volltextzugriff (PDF)

1 – 25 von 390

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(345)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management

Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial

Refocusing of Attention on Positive Events Using Monitoring-Based Feedback and Microinterventions for Patients With Chronic Musculoskeletal Pain in the PerPAIN Randomized Controlled Trial: Protocol for a Microrandomized Trial

Witnessing Christ: Contextual and Interconfessional Perspectives on Christology

Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers

Fibroblast growth on surface-modified dental implants: An in vitro study

A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation

Hair for brain trade-off, a metabolic bypass for encephalization

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain

Low absolute bioavailability of oral naloxone in healthy subjects

Dr. Meissner and colleagues reply to the Letter to the Editor from Andrew Wilcock entitled ‘Prolonged-release naloxone can cause systemic opioid withdrawal’

Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain

Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study

Mykosen – Bedeutung in Medizin und Zahnmedizin, Diagnostik und Therapie

Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial

Efficacy and tolerability of liposomal polyvinylpyrrolidone-iodine hydrogel for the localized treatment of chronic infective, inflammatory, dermatoses: an uncontrolled pilot study

Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers

PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain

PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain

Efficacy of Conventional and Liposomal Povidone–Iodine in Infected Mesh Skin Grafts: An Exploratory Study

Meeting the Challenges of Opioid-Induced Constipation in Chronic Pain Management – A Novel Approach

Prolonged release oxycodoneanaloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension

Suchergebnisse filtern